The Journal of Organic Chemistry
Page 8 of 11
8.2 Hz, 1H), 7.70−7.63 (m, 1H), 7.62−7.55 (m, 1H), 2-((Perfluorophenyl)thio)quinoxaline (5h). The product
4.19−4.01 (m, 1H), 2.25−1.13 (m, 10H); 13C{1H} NMR (100
MHz, CDCl3): δ 156.5, 145.2, 142.9, 139.8, 130.1, 129.3,
127.95, 129.94, 42.8, 33.0, 26.0, 25.8; HRMS (ESI+/TOF)
m/z: [M+Na]+ Calcd. for C14H16N2NaS 267.0932; Found
267.0935.
2-(Benzylthio)quinoxaline (5b). The product was purified
by preparative TLC (hexane/AcOEt = 9/1). Yellow liquid,
31.5 mg, 63%; 1H NMR (400 MHz, CDCl3): δ 8.57 (s, 1H), 8.00
(dd, J = 1.4, 8.2 Hz, 1H), 7.97 (dd, J = 1.4, 8.2 Hz, 1H),
7.74−7.67 (m, 1H), 7.66−7.58 (m, 1H), 7.48 (d, J = 7.3 Hz,
2H), 7.34−7.25 (m, 3H), 4.56 (s, 2H);13C{1H} NMR (100 MHz,
CDCl3): δ 155.7, 144.6, 142.7, 140.1, 137.4, 130.3, 129.35,
129.29, 128.7, 128.2, 127.9, 127.5, 33,8; HRMS (ESI+/TOF)
m/z: [M+Na]+ Calcd. for C15H12N2NaS 275.0619; Found
275.0612.
was purified by preparative TLC (hexane/AcOEt = 9/1).
White solid, 41.3 mg, 63%, mp 70-72 °C; 1H NMR (400 MHz,
CDCl3): δ 8.73 (s, 1H), 8.12−8.01 (m, 1H), 7.82−7.64 (m, 3H);
13C{1H} NMR (100 MHz, CDCl3): δ 151.5, 142.7, 142.6, 140.6,
130.8, 129.4, 129.3, 128.4; 19F (373 MHz, CDCl3): δ
−129.3-−129.9 (m, 2F), −148.8-−149.2 (m, 1F),
−159.7-−160.5 (m, 2F); HRMS (ESI+/TOF) m/z: [M+Na]+
Calcd. for C14H5F5N2NaS 350.9991; Found 350.9994.
2-((4-Fluorophenyl)thio)quinoxaline (5i). The product
was purified by preparative TLC (hexane/AcOEt = 9/1).
Colorless liquid, 35.3 mg, 69%; 1H NMR (400 MHz, CDCl3): δ
8.45 (s, 1H), 7.99 (dd, J = 1.6, 8.0 Hz, 1H), 7.85 (dd, J = 1.8,
7.8 Hz, 1H), 7.74−7.57 (m, 4H), 7.22-7.13 (m, 2H); 13C{1H}
NMR (100 MHz, CDCl3): δ 163.8 (d, JC−F = 250.2 Hz), 156.8,
143.2, 142.3, 140.0, 137,4 (d, JC−F = 8.6 Hz), 130.6, 129.3,
128.9, 128.3, 123.9 (d, JC−F = 2.9 Hz), 117.1 (d, JC−F = 22.0 Hz);
19F (373 MHz, CDCl3): δ −110.3; HRMS (ESI) m/z: [M+Na]+
Calcd. for C14H9FN2NaS 279.0368; Found 279.0365.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2-((4-Chlorobenzyl)thio)quinoxaline (5c). The product
was purified by preparative TLC (hexane/AcOEt = 9/1).
1
Yellow liquid, 35.5 mg, 62%; H NMR (400 MHz, CDCl3): δ
8.57 (s, 1H), 8.01 (dd, J = 1.4, 8.2 Hz, 1H), 7.95 (dd, J = 1.4,
8.2 Hz, 1H), 7.42 (d, J = 8.6 Hz, 2H), 7.26 (d, J = 8.6 Hz, 2H),
4.54 (s, 2H); 13C{1H} NMR (100 MHz, CDCl3): δ 155.2, 144.6,
142.6, 140.1, 136.1, 133.3, 130.6, 130.4, 129.4, 128.8, 128.3,
127.8, 33,0; HRMS (ESI+/TOF) m/z: [M+Na]+ Calcd. for
C15H11ClN2NaS 309.0229; Found 309.0225.
2-(Decylthio)quinoxaline (5d). The product was purified
by preparative TLC (hexane/AcOEt = 9/1). Colorless liquid,
52.6 mg, 87%; 1H NMR (400 MHz, CDCl3): δ 8.57 (s, 1H), 7.99
(dd, J = 1.4, 8.2 Hz, 1H), 7.91 (dd, J = 1.4, 8.2 Hz, 1H),
7.71−7.64 (m, 1H), 7.63−7.56 (m, 1H), 3.32 (t, J = 7.3 Hz, 2H),
1.90−0.80 (m, 19H);13C{1H} NMR (100 MHz, CDCl3): δ 156.6,
145.0, 142.9, 139.8, 130.1, 129.3, 127.9 (overlap), 32.0,
29.65, 29.60 (overlap), 29.4, 29.2, 29.1, 29.0, 22.8, 14.2;
HRMS (ESI+/TOF) m/z: [M+Na]+ Calcd. for C18H26N2NaS
325.1714; Found 325.1717.
2-((4-Methoxyphenyl)thio)quinoxaline (5j). The product
was purified by preparative TLC (hexane/AcOEt = 9/1).
White solid, 34.3 mg, 64%, mp 53−55 °C; 1H NMR (400 MHz,
CDCl3): δ 8.38 (s, 1H), 7.97 (dd, J = 1.4, 8.2 Hz, 1H), 7.89 (dd,
J = 1.4, 8.2 Hz, 1H), 7.72−7.55 (m, 4H), 7.04−6.97 (m, 2H),
3.87 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ 161.1, 158.2,
143.0, 142.2, 139.8, 137.2, 130.5, 129.2, 128.6, 128.3, 119.0,
115.5, 55.5; HRMS (ESI/TOF) m/z: [M+Na]+ Calcd. for
C15H12N2NaOS 291.0568; Found 291.0550.
2-(Naphthalen-1-ylthio)quinoxaline (5k). The product
was purified by preparative TLC (hexane/AcOEt = 9/1).
Colorless liquid, 40.9 mg, 71%; 1H NMR (400 MHz, CDCl3): δ
8.37 (d, J = 8.2 Hz, 1H), 8.15 (s, 1H), 8.02 (t, J = 6.6 Hz, 2H),
7.93 (d, J = 8.2 Hz, 2H), 7.87 (dd, J = 1.1, 8.4 Hz, 1H),
7.72−7.46 (m, 5H); 13C{1H} NMR (100 MHz, CDCl3): δ 157.6,
142.9, 142.2, 139.8, 135.9, 134.7, 134.6, 131.5, 130.5, 129.2,
128.9, 128.7, 128.3, 127.8, 126.9, 126.1, 125.8, 125.7; HRMS
(ESI+/TOF) m/z: [M+Na]+ Calcd. for C18H12N2NaS 311.0619;
Found 311.0616.
2-(Cyclohexylthio)-6,7-dimethylquinoxaline (5l). The
product was purified by preparative TLC (hexane/AcOEt =
9/1). White solid, 40.9 mg, 81%, mp 55−57 °C; 1H NMR (400
MHz, CDCl3): δ 8.45 (s, 1H), 7.72 (s, 1H), 7.67 (s, 1H), 4.15-
4.00 (m, 1H), 2.45 (s, 3H), 2.44 (s, 3H), 2.25−1.25 (m, 10H);
13C{1H} NMR (100 MHz, CDCl3): δ 155.1, 144.3, 141.8, 140.4,
138.7, 138.1, 128.4, 127.3, 42.8, 33.1, 26.1, 25.9, 20.3, 20.2;
HRMS (ESI+/TOF) m/z: [M+Na]+ Calcd. for C16H20N2NaS
295.1245; Found 295.1246.
2-(Sec-butylthio)quinoxaline (5e). The product was
purified by preparative TLC (hexane/AcOEt
= 9/1).
Colorless liquid, 38.8 mg, 89%; 1H NMR (400 MHz, CDCl3): δ
8.55 (s, 1H), 7.99 (dd, J = 1.6, 8.0 Hz, 1H), 7.90 (dd, J = 0.9,
8.2 Hz, 1H), 7.71−7.64 (m, 1H), 7.63−7.56 (m, 1H), 4.12
(quintet, J = 6.9 Hz, 1H), 1.91−1.70 (m, 2H), 1.48 (d, J = 6.9
Hz, 3H), 1.07 (t, J = 7.6 Hz, 3H); 13C{1H} NMR (100 MHz,
CDCl3): δ 156.8, 145.2, 142.9, 139.7, 130.1, 129.3, 127.9
(overlap), 41.4, 29.5, 20.6, 11.5; HRMS (ESI+/TOF) m/z:
[M+Na]+ Calcd. for C12H14N2NaS 241.0775; Found 241.0771.
2-(Tert-butylthio)quinoxaline (5f). The product was
purified by preparative TLC (hexane/AcOEt
= 9/1).
Colorless liquid, 31.0 mg, 71%; 1H NMR (400 MHz, CDCl3): δ
8.54 (s, 1H), 7.99 (dd, J = 1.4, 8.2 Hz, 1H), 7.95 (dd, J = 1.4,
8.2 Hz, 1H), 7.72−7.65 (m, 1H), 7.65−7.59 (m, 1H), 1.69 (s,
9H); 13C{1H} NMR (100 MHz, CDCl3): δ 157.3, 146.1, 142.6,
139.6, 130.0, 129.3, 128.2 (overlap), 49.1, 30.4; HRMS
(ESI+/TOF) m/z: [M+Na]+ Calcd. for C12H14N2NaS 241.0775;
Found 241.0778.
2-(Cyclohexylthio)-8-methylquinoxaline
(5m).
The
product was purified by preparative TLC (hexane/AcOEt =
9/1). White solid, 22.7 mg, 44%; 1H NMR (400 MHz, CDCl3):
δ 8.54 (s, 1H), 7.84 (dd, J = 1.6, 8.0 Hz, 1H), 7.58−7.45 (m,
2H), 4.20−4.00 (m, 1H), 2.74 (s, 3H), 2.40−1.30 (m, 10H);
13C{1H} NMR (100 MHz, CDCl3): δ 155.1, 144.7, 141.8, 139.7,
136.1, 130.2, 127.6, 127.0, 43.4, 32.8, 26.3, 25.9, 16.9; HRMS
(ESI+/TOF) m/z: [M+Na]+ Calcd. for C15H18N2NaS 281.1088;
Found 281.1086.
2-(Phenylthio)quinoxaline (5g).25 The product was
purified by preparative TLC (hexane/AcOEt
= 9/1).
Colorless liquid, 32.4 mg, 68%; 1H NMR (400 MHz, CDCl3): δ
8.43 (s, 1H), 7.98 (dd, J = 1.4, 8.2 Hz, 1H), 7.89 (dd, J = 1.4,
8.2 Hz, 1H), 7.72−7.60 (m, 4H), 7.49−7.44 (m, 3H); 13C{1H}
NMR (100 MHz, CDCl3): δ 157.3, 143.5, 142.2, 139.9, 135.1,
130.5, 129.9, 129.7, 129.2, 129.0, 128.8, 128.4.
2-(Cyclohexylthio)-5-methylquinoxaline
(5m’).
The
product was purified by preparative TLC (hexane/AcOEt =
9/1). White solid, 15.5 mg, 30%; 1H NMR (400 MHz, CDCl3):
δ 8.54 (s, 1H), 7.75 (d, J = 8.2 Hz, 1H), 7.56 (t, J = 7.8 Hz, 1H),
7.43 (d, J = 6.9 Hz, 1H), 4.20−4.00 (m, 1H), 2.74 (s, 3H),
ACS Paragon Plus Environment